nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—brain cancer—peripheral nervous system neoplasm	0.43	0.531	CtDrD
Hydroxyurea—head and neck cancer—peripheral nervous system neoplasm	0.38	0.47	CtDrD
Hydroxyurea—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.00456	0.199	CbGpPWpGaD
Hydroxyurea—RRM2—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.00376	0.164	CbGpPWpGaD
Hydroxyurea—RRM2—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.00215	1	CbGdCrCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00159	0.0691	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00141	0.0615	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00131	0.0569	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00116	0.0506	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00069	0.03	CbGpPWpGaD
Hydroxyurea—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000551	0.024	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000368	0.016	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000351	0.0153	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000338	0.0147	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000308	0.0134	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000303	0.0132	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000289	0.0126	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000282	0.0123	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000277	0.0121	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000274	0.0119	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000238	0.0103	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000226	0.00982	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000206	0.00899	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000196	0.00852	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000185	0.00806	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000177	0.00768	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.00017	0.0074	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.00017	0.00738	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000155	0.00676	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000152	0.00664	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000151	0.00656	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000142	0.00618	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000141	0.00614	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.00014	0.00608	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000135	0.00587	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GNS—peripheral nervous system neoplasm	0.000134	0.00583	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NME1—peripheral nervous system neoplasm	0.000128	0.00559	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—COX2—peripheral nervous system neoplasm	0.000124	0.00538	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000121	0.00525	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.00012	0.00521	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GNS—peripheral nervous system neoplasm	0.00011	0.0048	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.00011	0.00479	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NME1—peripheral nervous system neoplasm	0.000106	0.0046	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—COX2—peripheral nervous system neoplasm	0.000102	0.00443	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	9.77e-05	0.00425	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	9.71e-05	0.000589	CcSEcCtD
Hydroxyurea—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	9.71e-05	0.000589	CcSEcCtD
Hydroxyurea—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	9.71e-05	0.000589	CcSEcCtD
Hydroxyurea—Alopecia—Etoposide—peripheral nervous system neoplasm	9.7e-05	0.000589	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	9.68e-05	0.000587	CcSEcCtD
Hydroxyurea—Anaemia—Cisplatin—peripheral nervous system neoplasm	9.64e-05	0.000585	CcSEcCtD
Hydroxyurea—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.000585	CcSEcCtD
Hydroxyurea—Oedema—Vincristine—peripheral nervous system neoplasm	9.63e-05	0.000584	CcSEcCtD
Hydroxyurea—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	9.59e-05	0.000582	CcSEcCtD
Hydroxyurea—Infection—Vincristine—peripheral nervous system neoplasm	9.57e-05	0.00058	CcSEcCtD
Hydroxyurea—Asthenia—Topotecan—peripheral nervous system neoplasm	9.54e-05	0.000579	CcSEcCtD
Hydroxyurea—Anorexia—Alitretinoin—peripheral nervous system neoplasm	9.52e-05	0.000578	CcSEcCtD
Hydroxyurea—Asthenia—Isotretinoin—peripheral nervous system neoplasm	9.46e-05	0.000574	CcSEcCtD
Hydroxyurea—Asthenia—Tretinoin—peripheral nervous system neoplasm	9.46e-05	0.000574	CcSEcCtD
Hydroxyurea—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	9.44e-05	0.000573	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	9.43e-05	0.000572	CcSEcCtD
Hydroxyurea—Malaise—Cisplatin—peripheral nervous system neoplasm	9.41e-05	0.000571	CcSEcCtD
Hydroxyurea—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	9.37e-05	0.000568	CcSEcCtD
Hydroxyurea—Leukopenia—Cisplatin—peripheral nervous system neoplasm	9.34e-05	0.000567	CcSEcCtD
Hydroxyurea—Asthenia—Melphalan—peripheral nervous system neoplasm	9.34e-05	0.000567	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000565	CcSEcCtD
Hydroxyurea—Fatigue—Dactinomycin—peripheral nervous system neoplasm	9.29e-05	0.000564	CcSEcCtD
Hydroxyurea—Pain—Dactinomycin—peripheral nervous system neoplasm	9.22e-05	0.000559	CcSEcCtD
Hydroxyurea—Anorexia—Vincristine—peripheral nervous system neoplasm	9.18e-05	0.000557	CcSEcCtD
Hydroxyurea—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	9.16e-05	0.000556	CcSEcCtD
Hydroxyurea—Diarrhoea—Topotecan—peripheral nervous system neoplasm	9.09e-05	0.000552	CcSEcCtD
Hydroxyurea—Convulsion—Cisplatin—peripheral nervous system neoplasm	9.04e-05	0.000548	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	9.04e-05	0.00393	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	9.02e-05	0.000547	CcSEcCtD
Hydroxyurea—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	9.02e-05	0.000547	CcSEcCtD
Hydroxyurea—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000541	CcSEcCtD
Hydroxyurea—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	8.91e-05	0.000541	CcSEcCtD
Hydroxyurea—Diarrhoea—Melphalan—peripheral nervous system neoplasm	8.9e-05	0.00054	CcSEcCtD
Hydroxyurea—Somnolence—Alitretinoin—peripheral nervous system neoplasm	8.88e-05	0.000539	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	8.88e-05	0.000539	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	8.87e-05	0.000538	CcSEcCtD
Hydroxyurea—Anaemia—Etoposide—peripheral nervous system neoplasm	8.83e-05	0.000536	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	8.82e-05	0.000535	CcSEcCtD
Hydroxyurea—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	8.8e-05	0.000534	CcSEcCtD
Hydroxyurea—Dizziness—Topotecan—peripheral nervous system neoplasm	8.79e-05	0.000533	CcSEcCtD
Hydroxyurea—Discomfort—Cisplatin—peripheral nervous system neoplasm	8.77e-05	0.000532	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—BIRC5—peripheral nervous system neoplasm	8.74e-05	0.0038	CbGpPWpGaD
Hydroxyurea—Dizziness—Tretinoin—peripheral nervous system neoplasm	8.72e-05	0.000529	CcSEcCtD
Hydroxyurea—Dizziness—Isotretinoin—peripheral nervous system neoplasm	8.72e-05	0.000529	CcSEcCtD
Hydroxyurea—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	8.69e-05	0.000527	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	8.63e-05	0.000523	CcSEcCtD
Hydroxyurea—Malaise—Etoposide—peripheral nervous system neoplasm	8.62e-05	0.000523	CcSEcCtD
Hydroxyurea—Fatigue—Alitretinoin—peripheral nervous system neoplasm	8.61e-05	0.000523	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000523	CcSEcCtD
Hydroxyurea—Face oedema—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000521	CcSEcCtD
Hydroxyurea—Leukopenia—Etoposide—peripheral nervous system neoplasm	8.55e-05	0.000519	CcSEcCtD
Hydroxyurea—Constipation—Alitretinoin—peripheral nervous system neoplasm	8.54e-05	0.000518	CcSEcCtD
Hydroxyurea—Pain—Alitretinoin—peripheral nervous system neoplasm	8.54e-05	0.000518	CcSEcCtD
Hydroxyurea—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	8.52e-05	0.000517	CcSEcCtD
Hydroxyurea—Oedema—Cisplatin—peripheral nervous system neoplasm	8.51e-05	0.000517	CcSEcCtD
Hydroxyurea—Infection—Cisplatin—peripheral nervous system neoplasm	8.46e-05	0.000513	CcSEcCtD
Hydroxyurea—Vomiting—Topotecan—peripheral nervous system neoplasm	8.45e-05	0.000513	CcSEcCtD
Hydroxyurea—Vomiting—Tretinoin—peripheral nervous system neoplasm	8.38e-05	0.000509	CcSEcCtD
Hydroxyurea—Vomiting—Isotretinoin—peripheral nervous system neoplasm	8.38e-05	0.000509	CcSEcCtD
Hydroxyurea—Rash—Topotecan—peripheral nervous system neoplasm	8.38e-05	0.000509	CcSEcCtD
Hydroxyurea—Dermatitis—Topotecan—peripheral nervous system neoplasm	8.37e-05	0.000508	CcSEcCtD
Hydroxyurea—Decreased appetite—Vincristine—peripheral nervous system neoplasm	8.37e-05	0.000508	CcSEcCtD
Hydroxyurea—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	8.35e-05	0.000507	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	8.34e-05	0.000506	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000506	CcSEcCtD
Hydroxyurea—Headache—Topotecan—peripheral nervous system neoplasm	8.33e-05	0.000505	CcSEcCtD
Hydroxyurea—Rash—Isotretinoin—peripheral nervous system neoplasm	8.31e-05	0.000504	CcSEcCtD
Hydroxyurea—Rash—Tretinoin—peripheral nervous system neoplasm	8.31e-05	0.000504	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	8.31e-05	0.000504	CcSEcCtD
Hydroxyurea—Dermatitis—Tretinoin—peripheral nervous system neoplasm	8.31e-05	0.000504	CcSEcCtD
Hydroxyurea—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	8.31e-05	0.000504	CcSEcCtD
Hydroxyurea—Fatigue—Vincristine—peripheral nervous system neoplasm	8.3e-05	0.000504	CcSEcCtD
Hydroxyurea—Convulsion—Etoposide—peripheral nervous system neoplasm	8.28e-05	0.000502	CcSEcCtD
Hydroxyurea—Vomiting—Melphalan—peripheral nervous system neoplasm	8.27e-05	0.000502	CcSEcCtD
Hydroxyurea—Skin disorder—Cisplatin—peripheral nervous system neoplasm	8.27e-05	0.000502	CcSEcCtD
Hydroxyurea—Headache—Isotretinoin—peripheral nervous system neoplasm	8.26e-05	0.000501	CcSEcCtD
Hydroxyurea—Headache—Tretinoin—peripheral nervous system neoplasm	8.26e-05	0.000501	CcSEcCtD
Hydroxyurea—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	8.23e-05	0.0005	CcSEcCtD
Hydroxyurea—Constipation—Vincristine—peripheral nervous system neoplasm	8.23e-05	0.0005	CcSEcCtD
Hydroxyurea—Pain—Vincristine—peripheral nervous system neoplasm	8.23e-05	0.0005	CcSEcCtD
Hydroxyurea—Rash—Melphalan—peripheral nervous system neoplasm	8.21e-05	0.000498	CcSEcCtD
Hydroxyurea—Dermatitis—Melphalan—peripheral nervous system neoplasm	8.2e-05	0.000497	CcSEcCtD
Hydroxyurea—Anorexia—Cisplatin—peripheral nervous system neoplasm	8.12e-05	0.000492	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ENO2—peripheral nervous system neoplasm	8.11e-05	0.00353	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	8.08e-05	0.00049	CcSEcCtD
Hydroxyurea—Discomfort—Etoposide—peripheral nervous system neoplasm	8.04e-05	0.000488	CcSEcCtD
Hydroxyurea—Breast disorder—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000488	CcSEcCtD
Hydroxyurea—Face oedema—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000482	CcSEcCtD
Hydroxyurea—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	7.94e-05	0.000482	CcSEcCtD
Hydroxyurea—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	7.9e-05	0.000479	CcSEcCtD
Hydroxyurea—Nausea—Topotecan—peripheral nervous system neoplasm	7.89e-05	0.000479	CcSEcCtD
Hydroxyurea—Nausea—Isotretinoin—peripheral nervous system neoplasm	7.83e-05	0.000475	CcSEcCtD
Hydroxyurea—Nausea—Tretinoin—peripheral nervous system neoplasm	7.83e-05	0.000475	CcSEcCtD
Hydroxyurea—Infection—Etoposide—peripheral nervous system neoplasm	7.75e-05	0.00047	CcSEcCtD
Hydroxyurea—Asthenia—Dactinomycin—peripheral nervous system neoplasm	7.73e-05	0.000469	CcSEcCtD
Hydroxyurea—Nausea—Melphalan—peripheral nervous system neoplasm	7.73e-05	0.000469	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000468	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	7.64e-05	0.000463	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.63e-05	0.00332	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Vincristine—peripheral nervous system neoplasm	7.61e-05	0.000462	CcSEcCtD
Hydroxyurea—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	7.59e-05	0.000461	CcSEcCtD
Hydroxyurea—Skin disorder—Etoposide—peripheral nervous system neoplasm	7.58e-05	0.00046	CcSEcCtD
Hydroxyurea—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000457	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000451	CcSEcCtD
Hydroxyurea—Anorexia—Etoposide—peripheral nervous system neoplasm	7.43e-05	0.000451	CcSEcCtD
Hydroxyurea—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	7.4e-05	0.000449	CcSEcCtD
Hydroxyurea—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	7.37e-05	0.000447	CcSEcCtD
Hydroxyurea—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	7.36e-05	0.000447	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	7.35e-05	0.000446	CcSEcCtD
Hydroxyurea—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000443	CcSEcCtD
Hydroxyurea—Pain—Cisplatin—peripheral nervous system neoplasm	7.28e-05	0.000442	CcSEcCtD
Hydroxyurea—Neutropenia—Epirubicin—peripheral nervous system neoplasm	7.19e-05	0.000436	CcSEcCtD
Hydroxyurea—Dysuria—Epirubicin—peripheral nervous system neoplasm	7.19e-05	0.000436	CcSEcCtD
Hydroxyurea—Asthenia—Alitretinoin—peripheral nervous system neoplasm	7.17e-05	0.000435	CcSEcCtD
Hydroxyurea—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	7.09e-05	0.00043	CcSEcCtD
Hydroxyurea—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	7.02e-05	0.000426	CcSEcCtD
Hydroxyurea—Weight increased—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000425	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000423	CcSEcCtD
Hydroxyurea—Dyspnoea—Etoposide—peripheral nervous system neoplasm	6.95e-05	0.000422	CcSEcCtD
Hydroxyurea—Somnolence—Etoposide—peripheral nervous system neoplasm	6.93e-05	0.000421	CcSEcCtD
Hydroxyurea—Asthenia—Vincristine—peripheral nervous system neoplasm	6.91e-05	0.000419	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000416	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000416	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000416	CcSEcCtD
Hydroxyurea—Vomiting—Dactinomycin—peripheral nervous system neoplasm	6.85e-05	0.000416	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—BCHE—peripheral nervous system neoplasm	6.85e-05	0.00298	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	6.84e-05	0.000415	CcSEcCtD
Hydroxyurea—Rash—Dactinomycin—peripheral nervous system neoplasm	6.8e-05	0.000412	CcSEcCtD
Hydroxyurea—Decreased appetite—Etoposide—peripheral nervous system neoplasm	6.78e-05	0.000411	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.00041	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	6.73e-05	0.000409	CcSEcCtD
Hydroxyurea—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	6.73e-05	0.000408	CcSEcCtD
Hydroxyurea—Fatigue—Etoposide—peripheral nervous system neoplasm	6.72e-05	0.000408	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000408	CcSEcCtD
Hydroxyurea—Stomatitis—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000405	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ENO2—peripheral nervous system neoplasm	6.68e-05	0.00291	CbGpPWpGaD
Hydroxyurea—Pain—Etoposide—peripheral nervous system neoplasm	6.67e-05	0.000405	CcSEcCtD
Hydroxyurea—Constipation—Etoposide—peripheral nervous system neoplasm	6.67e-05	0.000405	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—peripheral nervous system neoplasm	6.65e-05	0.000404	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	6.65e-05	0.000404	CcSEcCtD
Hydroxyurea—Dizziness—Alitretinoin—peripheral nervous system neoplasm	6.61e-05	0.000401	CcSEcCtD
Hydroxyurea—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.59e-05	0.0004	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.54e-05	0.00284	CbGpPWpGaD
Hydroxyurea—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000393	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	6.47e-05	0.00282	CbGpPWpGaD
Hydroxyurea—Weight increased—Doxorubicin—peripheral nervous system neoplasm	6.47e-05	0.000393	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—TH—peripheral nervous system neoplasm	6.44e-05	0.0028	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	6.43e-05	0.00039	CcSEcCtD
Hydroxyurea—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.4e-05	0.000388	CcSEcCtD
Hydroxyurea—Dizziness—Vincristine—peripheral nervous system neoplasm	6.37e-05	0.000386	CcSEcCtD
Hydroxyurea—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.35e-05	0.000386	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000385	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000385	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000385	CcSEcCtD
Hydroxyurea—Rash—Alitretinoin—peripheral nervous system neoplasm	6.3e-05	0.000382	CcSEcCtD
Hydroxyurea—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	6.29e-05	0.000382	CcSEcCtD
Hydroxyurea—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.27e-05	0.000381	CcSEcCtD
Hydroxyurea—Headache—Alitretinoin—peripheral nervous system neoplasm	6.26e-05	0.00038	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000377	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.000375	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000375	CcSEcCtD
Hydroxyurea—Body temperature increased—Etoposide—peripheral nervous system neoplasm	6.17e-05	0.000374	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000373	CcSEcCtD
Hydroxyurea—Vomiting—Vincristine—peripheral nervous system neoplasm	6.12e-05	0.000371	CcSEcCtD
Hydroxyurea—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.11e-05	0.000371	CcSEcCtD
Hydroxyurea—Rash—Vincristine—peripheral nervous system neoplasm	6.07e-05	0.000368	CcSEcCtD
Hydroxyurea—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.07e-05	0.000368	CcSEcCtD
Hydroxyurea—Headache—Vincristine—peripheral nervous system neoplasm	6.03e-05	0.000366	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000364	CcSEcCtD
Hydroxyurea—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.94e-05	0.00036	CcSEcCtD
Hydroxyurea—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	5.83e-05	0.000353	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	5.79e-05	0.00252	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	5.75e-05	0.000349	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000347	CcSEcCtD
Hydroxyurea—Nausea—Vincristine—peripheral nervous system neoplasm	5.72e-05	0.000347	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000346	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—BCHE—peripheral nervous system neoplasm	5.64e-05	0.00246	CbGpPWpGaD
Hydroxyurea—Asthenia—Etoposide—peripheral nervous system neoplasm	5.6e-05	0.00034	CcSEcCtD
Hydroxyurea—Angiopathy—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000339	CcSEcCtD
Hydroxyurea—Chills—Epirubicin—peripheral nervous system neoplasm	5.52e-05	0.000335	CcSEcCtD
Hydroxyurea—Alopecia—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.00033	CcSEcCtD
Hydroxyurea—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.41e-05	0.000328	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.38e-05	0.00234	CbGpPWpGaD
Hydroxyurea—Rash—Cisplatin—peripheral nervous system neoplasm	5.37e-05	0.000326	CcSEcCtD
Hydroxyurea—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.36e-05	0.000325	CcSEcCtD
Hydroxyurea—Erythema—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000325	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.34e-05	0.000324	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TH—peripheral nervous system neoplasm	5.3e-05	0.00231	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GNAS—peripheral nervous system neoplasm	5.26e-05	0.00229	CbGpPWpGaD
Hydroxyurea—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000313	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.16e-05	0.00225	CbGpPWpGaD
Hydroxyurea—Dizziness—Etoposide—peripheral nervous system neoplasm	5.16e-05	0.000313	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.00031	CcSEcCtD
Hydroxyurea—Nausea—Cisplatin—peripheral nervous system neoplasm	5.06e-05	0.000307	CcSEcCtD
Hydroxyurea—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000305	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000302	CcSEcCtD
Hydroxyurea—Vomiting—Etoposide—peripheral nervous system neoplasm	4.96e-05	0.000301	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000301	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.0003	CcSEcCtD
Hydroxyurea—Rash—Etoposide—peripheral nervous system neoplasm	4.92e-05	0.000298	CcSEcCtD
Hydroxyurea—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.91e-05	0.000298	CcSEcCtD
Hydroxyurea—Headache—Etoposide—peripheral nervous system neoplasm	4.89e-05	0.000296	CcSEcCtD
Hydroxyurea—Malaise—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000293	CcSEcCtD
Hydroxyurea—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000291	CcSEcCtD
Hydroxyurea—Convulsion—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000282	CcSEcCtD
Hydroxyurea—Nausea—Etoposide—peripheral nervous system neoplasm	4.63e-05	0.000281	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000279	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000278	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000275	CcSEcCtD
Hydroxyurea—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000273	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000271	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000269	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	4.39e-05	0.00191	CbGpPWpGaD
Hydroxyurea—Oedema—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000265	CcSEcCtD
Hydroxyurea—Infection—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000264	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GNAS—peripheral nervous system neoplasm	4.33e-05	0.00188	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.3e-05	0.00187	CbGpPWpGaD
Hydroxyurea—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000261	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.00026	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.00026	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.25e-05	0.00185	CbGpPWpGaD
Hydroxyurea—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.25e-05	0.000258	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000254	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000253	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000253	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000245	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000244	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000241	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.00024	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.93e-05	0.000238	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MYC—peripheral nervous system neoplasm	3.92e-05	0.00171	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000237	CcSEcCtD
Hydroxyurea—Somnolence—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.000236	CcSEcCtD
Hydroxyurea—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000234	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000234	CcSEcCtD
Hydroxyurea—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.8e-05	0.000231	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000229	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000229	CcSEcCtD
Hydroxyurea—Constipation—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000227	CcSEcCtD
Hydroxyurea—Pain—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000227	CcSEcCtD
Hydroxyurea—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000219	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000219	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000218	CcSEcCtD
Hydroxyurea—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000216	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.52e-05	0.000213	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000212	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000212	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.00021	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.00021	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.00021	CcSEcCtD
Hydroxyurea—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000202	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TP53—peripheral nervous system neoplasm	3.22e-05	0.0014	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.000195	CcSEcCtD
Hydroxyurea—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000194	CcSEcCtD
Hydroxyurea—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.00019	CcSEcCtD
Hydroxyurea—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000182	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.000181	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.9e-05	0.00126	CbGpPWpGaD
Hydroxyurea—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000176	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.000175	CcSEcCtD
Hydroxyurea—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.78e-05	0.000169	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000168	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—peripheral nervous system neoplasm	2.76e-05	0.000167	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000167	CcSEcCtD
Hydroxyurea—Headache—Epirubicin—peripheral nervous system neoplasm	2.74e-05	0.000166	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000162	CcSEcCtD
Hydroxyurea—Nausea—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000158	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.57e-05	0.000156	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—peripheral nervous system neoplasm	2.55e-05	0.000155	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.55e-05	0.000155	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—peripheral nervous system neoplasm	2.53e-05	0.000154	CcSEcCtD
Hydroxyurea—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000146	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	2.1e-05	0.000914	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	2.01e-05	0.000876	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.94e-05	0.000844	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—peripheral nervous system neoplasm	1.42e-05	0.000618	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.27e-05	0.000554	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—peripheral nervous system neoplasm	1.17e-05	0.000509	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.07e-05	0.000468	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.03e-05	0.000446	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.01e-05	0.00044	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	8.25e-06	0.000359	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	8.1e-06	0.000352	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.23e-06	9.69e-05	CbGpPWpGaD
